欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

Cancer

货号 产品名 CAS号 信息
CSN19878 20(R)-Ginsenoside Rh2 112246-15-8 20(R)-Ginsenoside Rh2 has anticancer effects and can increase inchoate apoptotic rate, reduce apoptotic rate significantly, enhance the activity of caspase-3 and induces apoptosis in human lung adenocarcinoma A549 cells. It is a natural product isolated and purified from the roots of Panax ginseng C. A. Mey..
CSN19872 3-Hydroxy-2,9,10-trimethoxy-5,6-dihydroisoquinolino[3,2-a]isoquinolin-7-ium chloride 6681-15-8 Jatrorrhizine HCl is a protoberberine alkaloid isolated from some plant species like Enantia chlorantha. It can inhibit MAO-A and MAO-B noncompetitively with IC50 value of 4μM and 62μM, respectively. Also, it has antiinflammatory, antimicrobial and antifungal activity.
CSN19926 Irigenin 548-76-5 Irigenin is a naturally occuring O-methylated isoflavone.
CSN19860 5-Hydroxy-2-methylnaphthalene-1,4-dione 481-42-5 Plumbagin is an anticancer agent, induces G2/M cell cycle arrest and apoptosis in A549 cells through JNK-dependent p53 Ser15 phosphorylation and inhibits A549 and MDA-MD-231 tumour xenograft growth in nude mice.
CSN20001 Thiolutin 87-11-6 Thiolutin is an antibiotic which inhibits bacterial RNA polymerase. Inhibits adhesion of HUVEC cells to vitronectin (IC50 = 0.83 mM) and subsequently reduces paxillin levels. Thiolutin also suppresses tumor cell-induced angiogenesis.
CSN19954 Cyasterone 17086-76-9 Cyasterone is an inhibitor of EGFR that maybe a promising anti-cancer agent espcially in skin carcinoma.
CSN19857 KB SRC 4 1380088-03-8 KB SRC 4 is a potent and selective c-Src inhibitor (Ki = 44 nM) and does not inhibit c-Abl at concentrations up to 125 μM.
CSN19822 RSM-932A 850807-63-5 RSM-932A is an anticancer drug targeting the human choline kinase alpha, an enzyme involved in increased lipid metabolism of cancer cells.
CSN19821 Maytansine 35846-53-8 Maitansine is a cytotoxic agent. It inhibits the assembly of microtubules by binding to tubulin at the rhizoxin binding site.
CSN20037 SGD-1882 1222490-34-7 Pyrrolobenzodiazepine dimer (PDB dimer) is a DNA crosslinking agent that inhibits DNA synthesis.
CSN20168 (±)-Zanubrutinib 1633350-06-7 BGB-3111 is a potent, selective and orally available Bruton's tyrosine kinase (Btk) inhibitor.
CSN20017 NVS-PAK1-1 1783816-74-9 NVS-PAK1-1 is a potent allosteric inhibitor of p21-activated kinase PAK1, a serine-threonine kinase that is upregulated in many cancers. NVS-PAK1-1 has an IC50 value of 5 nM for dephoshorylated PAK1 and 6 nM for phosphorylated PAK1 in an in vitro dephosphorylation assay.
CSN20042 DM4 796073-69-3 Maytansinoid DM4 is a tubulin inhibitor, inhibits the assemblyof microtubules by binding to tubulin, with a linker structure can create an antibody-drug conjugate (ADC).
CSN20156 Pyrotinib dimaleate 1397922-61-0 Pyrotinib maleate is an irreversible pan-ErbB receptor tyrosine kinase inhibitor, in patients with HER2-Positive metastatic breast cancer.
CSN20035 Tubulysin B 205304-87-6 Tubulysin B is a myxobacterial product that can function as an antiangiogenic agent in many in vitro assays with anti-microtubule, anti-mitotic, an apoptosis inducer, anticancer, anti-angiogenic, and antiproliferative activity.
CSN20045 Duocarmycin A 118292-34-5 Duocarmycin A is a DNA alkylator agent belonging to duocarmycins family that inhibits DNA synthesis.
CSN20036 (-)-Irofulven 158440-71-2 Irofulven is a DNA alkylator agent that inhibits DNA synthesis.
CSN20048 Rachelmycin 69866-21-3 CC-1065 is a DNA alkylator agent belonging to duocarmycins family that inhibits DNA synthesis.
CSN19868 Chelerythrine 34316-15-9 Chelerythrine, a natural product isolated and purified from the herbs of Chelidonium majus with potent antimanic, antiproliferatvie and antitumor effect, can inhibit telomerase activity, and is a well-known protein kinase C inhibitor.
CSN20016 Coralyne 6872-73-7 Coralyne is a cytotoxic agent trageting topoisoerase I, used in combinational chemotherapy to improve the effectiveness in combating proliferation of cancer cells.
CSN20180 PD184161 212631-67-9 PD184161 is an orally-active MEK inhibitor with antitumor effects in HCC in vitro and in vivo that appear to correlate with suppression of MEK activity.
CSN20011 Theliatinib 1353644-70-8 Theliatinib, is a small molecule, epidermal growth factor receptor tyrosine kinase inhibitor with potential antineoplastic and anti-angiogenesis activities.
CSN20012 FGFR4 Inhibitor C(-)-11 2020395-38-2 FGFR4 inhibitor C(-)-11 is a highly potent FGFR4 inhibitor with selectivity over FGFR1 with good stability and CYP inhibition.
CSN20027 Sirtuin Inhibitor C18 1392810-44-4 Sirtuin inhibitor C18 is a histone deacetylase class III inhibitor of sirtuin 1 and 2 exerting antiproliferative activity against cancer cell lines.
CSN20000 Neladenoson dalanate 1239309-58-0 Neladenoson dalanate is a potent and selective adenosine A1 receptor agonist, and potentially useful for treatment of cardiovascular diseases.
CSN20054 DM1-SMe 138148-68-2 DM1-SMe is a tubulin inhibitor, inhibits the assemblyof microtubules by binding to tubulin, with a linker structure can create an antibody-drug conjugate (ADC).
CSN20040 Esperamicin A1 99674-26-7 Esperamicin A1 is a DNA crosslinking agent that inhibits DNA synthesis.
CSN20041 DM3 796073-54-6 DM3 is a tubulin inhibitor, inhibits the assemblyof microtubules by binding to tubulin, with a linker structure can create an antibody-drug conjugate (ADC).
CSN20043 DM3-SMe 796073-70-6 DM3-SMe is a tubulin inhibitor, inhibits the assemblyof microtubules by binding to tubulin, with a linker structure can create an antibody-drug conjugate (ADC).
CSN20053 Sabarubicin 211100-13-9 Sabarubicin is a Top II inhibitor with anticancer activity.
CSN20038 Thailanstatin A 1426953-21-0 Thailanstatin A is a spliceosome inhibitor that disrupts cancer by inhibiting DNA-editing machinery.
CSN20044 DM4-SMe 796073-68-2 DM4-Me is a tubulin inhibitor, inhibits the assemblyof microtubules by binding to tubulin, with a linker structure can create an antibody-drug conjugate (ADC).
CSN20039 Tubulysin M 936691-46-2 Tubulysin M is a myxobacterial product that can function as an antiangiogenic agent in many in vitro assays with anti-microtubule, anti-mitotic, an apoptosis inducer, anticancer, anti-angiogenic, and antiproliferative activity.
CSN20155 XIAP/cIAP1 antagonist-1 1403898-55-4 AT-IAP is a potent, orally bioavailable, dual antagonist of XIAP and cIAP1 which is functioning in anti-apoptotic and pro-survival signaling pathways.
CSN20046 Duocarmycin MA 1613286-57-9 Seco-duocarmycin MA is a DNA alkylator agent belonging to duocarmycins family that inhibits DNA synthesis.
CSN20165 GDC-0425 1200129-48-1 GDC-0425 is an oral, selective Chk1 inhibitor. GDC-0425 enhances gemcitabine (gem) efficacy in tumor xenograft models, and shows greater chemopotentiation in cancer cell lines lacking p53 activity.
CSN20047 Seco-Duocarmycin SA 144667-38-9 Seco-duocarmycin SA is a DNA alkylator agent belonging to duocarmycins family that inhibits DNA synthesis.
CSN20166 SU11652 326914-10-7 SU11652 is a sunitinib analog with anti-tyrosine-kinase activity, also is identified as a potential inhibitor for Leishmania major (Lm) nucleoside diphosphate kinases NDK and structural studies indicated that this molecule binds to the active site of LmNDK in a similar conformation to nucleotides, mimicking natural substrates.
CSN20049 Duocarmycin SA 130288-24-3 Duocarmycin SA is a DNA alkylator agent belonging to duocarmycins family that inhibits DNA synthesis.
CSN20159 SC-43 1400989-25-4 SC-43 is an src-homology protein tyrosine phosphatase-1 (SHP-1) agonist which reduces liver fibrosis.
CSN20051 Duocarmycin MB 1613286-58-0 Seco-duocarmycin MB is a DNA alkylator agent belonging to duocarmycins family that inhibits DNA synthesis.
CSN20162 CAM4066 2101206-81-7 CAM4066 is a selective Casein Kinase 2α (CK2α) inhibitor.
CSN20052 Seco-Duocarmycin TM 236102-87-7 Seco-duocarmycin TM is a DNA alkylator agent belonging to duocarmycins family that inhibits DNA synthesis.
CSN20163 Tegatrabetan 1227637-23-1 beta-Catenin inhibitor BC2059 is efficacious as monotherapy or in combination with proteasome inhibitor bortezomib in multiple myeloma.
CSN20172 EML-631 2101206-36-2 EML631 interacts with the Tudor-domain-containing protein Spindlin1 (SPIN1), blocking its ability to 'read' H3K4me3 marks and inhibit its transcriptional-coactivator activity.
CSN20164 PP2A-β-Catenin Inhibitor CS-11 N/A PP2A-β-Catenin inhibitor CS-11 a small molecule inhibitor of PP2A-β-catenin signaling that limits both in vivo tumor growth and metastasis.
<< PREV 3 4 5 6 7 8 9 10 11 NEXT >>
联系
我们